Amacathera
3 known investors
AmacaThera develops a tunable hydrogel drug-delivery platform for long-acting therapeutic administration across various clinical applications, including pain management, oncology, and post-surgical care. The company licenses its proprietary formulation technology to pharmaceutical partners for product development and commercialization.